AOD9604

A modified fragment of human growth hormone studied for lipolytic activity without affecting IGF-1.

Supplied as a research-use-only preparation from a cGMP-compliant, ISO-certified facility and guaranteed to a minimum of 99% purity. Each lot is submitted for independent third-party analysis, and the certificate of analysis is tied to the lot code printed on the vial you receive.

Not for human or animal consumption. This compound is intended strictly for in-vitro laboratory and scientific research use. It is not approved by the FDA and is not for medical, diagnostic, or therapeutic use.

Form

Lyophilized powder

Lyophilized storage

Keep dry and sealed. Store per the vial label; protect from light.

Solvent

Bacteriostatic water (0.9% benzyl alcohol)

Reconstituted storage

Refrigerate after reconstitution. Do not shake — swirl to dissolve.

Handling

Allow the vial to reach room temperature before opening to limit condensation.

Category

Regenerative Research

Class

Modified fragment of human growth hormone

SKU

AOD-5

Purity

≥99% guaranteed

Molecular formula

C78H123N23O23S2 · 1815.1 g/mol

Origin

Manufactured in the USA

Availability

In stock

AOD-9604 is a modified fragment corresponding to the C-terminal region (residues 176–191) of human growth hormone.

Literature examines lipolytic signalling in adipose tissue models, separate from the growth-promoting and IGF-1 effects associated with the full growth-hormone molecule.

On the evidence base. The peer-reviewed literature on this compound specifically is thin. The primary reference below is a 2004 drug-profile article; the second is a broad 2026 review that discusses it among other peptides. Treat the evidence base as early.